Drawing for D DAIICHI

USPTO serial 77665262

D DAIICHI

Reviewed by CopyMark Law Group

Reg. 3727558Status 710
Filing date
Status date
Registration date
Dec 22, 2009
Examiner
AGOSTO, GISELLE MARIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with D DAIICHI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebeccah Gan

Rebeccah Gan WENDEROTH, LIND & PONACK, L.L.P.1030 15th Street, NW Suite 400 EastWashington, DC 20005UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in the manufacture of pharmaceuticals, cosmetics and food additives, namely, acrinol, D-calcium pantothenate, dexpanthenol, pantethine-A, disodium adenosine triphosphate, epsilon-aminocaproic acid, gamma-aminobutyric acid, pyridoxal 5-phosphate, pyridoxine hydrochloride, sulfadimethoxine, sulfadimethoxine sodium, sulfamonomethoxine sodium, sulpyrine, tranexamic acid, sulfamonomethoxine, P-hydroxyphenyl propionic acid; food preservative compositions; plasticizers for use as high polymer stabilizers for plastics and paint; chemical additives for use in the manufacture of food; chemical antioxidants for use in the manufacture of drinks, cakes, flavoring agents, dairy products and fish paste products; chemical germination inhibitors, namely, gibberellins for grapes, oranges, and domestic and agricultural use; diagnostic reagents for scientific use; diagnostic preparations for in vitro biological tests, namely, for urine and blood test, for blood glucose tests, for clotting tests, all for scientific use; enzyme preparations for in vitro scientific use; soil conditions, namely, soil improving agents and plant growth regulators for agriculture use; chemical preparations in the nature of tetrodotoxins for scientific research useSECTION 8 - CANCELLED
005Central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital andrenal hyperplasia, rheumatoid arthritis, rheumatic fever, Crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives; urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis, and dermatophytosis, anthelminitics for the treatment of threadworm and toxoplasmosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidium in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicide, fungicides, insecticides, bactericides and rodenticides for domestic and/or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment of cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, antiparkinsonism drugs, minor tranquilizers, and antianxiety agents; preparations for the treatment of hypertension or high blood pressure; preparations for the treatment of diabetes; preparations for antihypertensive agent; preparations for antihypertensive agent combined with a diuretic; preparations for the treatment of ear infections; preparations for treatment of Sjogren's syndrome and/or XerosisSECTION 8 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 29, 2016C8..CANCELLED SEC. 8 (6-YR)
Aug 11, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 11, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 22, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 6, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 16, 2009NPUBNOTICE OF PUBLICATION
Aug 31, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 28, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 28, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 28, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2009ALIEASSIGNED TO LIE
Aug 17, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 24, 2009CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2009DOCKASSIGNED TO EXAMINER
Feb 18, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 11, 2009MDSCNOTICE OF DESIGN SEARCH CODE MAILED
Feb 10, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2009NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance